Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - levodopum, carbidopum - comprimés - levodopum 100 mg, carbidopum 25 mg pour carbidopum monohydricum, color.: e 129, e 132, excipiens pro compresso. - morbus parkinson - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - levodopum, carbidopum - comprimés - levodopum 200 mg, carbidopum 50 mg à carbidopum monohydricum, color.: e 129, e 132, excipiens pro compresso. - morbus parkinson - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - capsules - levodopum 50.00 mg, benserazidum 12.50 mg ut benserazidi hydrochloridum, mannitolum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (nigrum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbus parkinson, des jambes sans repos-syndrom - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - capsules - levodopum 100.0 mg, benserazidum 25.0 mg ut benserazidi hydrochloridum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (rubrum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbus parkinson, des jambes sans repos-syndrom - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - capsules - levodopum 200.0 mg, benserazidum 50.0 mg ut benserazidi hydrochloridum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (rubrum), e 172 (flavum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbus parkinson, des jambes sans repos-syndrom - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

organon gmbh - levodopum, carbidopum - comprimés - levodopum 100 mg, carbidopum 25 mg pour carbidopum monohydricum, color.: e 104, excipiens pro compresso. - morbus parkinson - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

organon gmbh - levodopum, carbidopum - comprimés - levodopum 250 mg, carbidopum 25 mg pour carbidopum monohydricum, color.: e 132, excipiens pro compresso. - morbus parkinson - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - comprimés - levodopum 200.00 mg, benserazidum 50.00 mg ut benserazidi hydrochloridum, mannitolum, calcii hydrogenophosphas, cellulosum microcristallinum, amylum pregelificatum, crospovidonum, ethylcellulosum, e 172 (rubrum), silica colloidalis anhydrica, natrii docusas corresp. natrium 0.01 mg, magnesii stearas, pro compresso. - morbus parkinson, des jambes sans repos-syndrom - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - comprimés - levodopum 100.00 mg, benserazidum 25.00 mg ut benserazidi hydrochloridum, mannitolum, calcii hydrogenophosphas, cellulosum microcristallinum, amylum pregelificatum, crospovidonum, ethylcellulosum, e 172 (rubrum), silica colloidalis anhydrica, natrii docusas corresp. natrium 0.005 mg, magnesii stearas, pro compresso. - morbus parkinson, des jambes sans repos-syndrom - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - comprimés pour suspension buvable - levodopum 50.00 mg, benserazidum 12.50 mg ut benserazidi hydrochloridum, acidum citricum, amylum pregelificatum, cellulosum microcristallinum, magnesii stearas pro compresso. - morbus parkinson, des jambes sans repos-syndrom - synthetika